Investigation Overview
December 1, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of BIOLASE Inc (NASDAQ:BIOL) was announced over potential breaches of fiduciary duties by certain officers and directors at BIOLASE Inc.
The investigation by a law firm concerns whether certain BIOLASE officers and directors breached their fiduciary duties.
BIOLASE Inc reported that its annual Total Revenue rose from $47.66 million in 2014 to $48.48 million in 2015 and that its Net Loss increased from $18.93 million in 2014 to $20.28 million in 2015.
Shares of BIOLASE Inc (NASDAQ:BIOL) declined from $2.97 per share in late 2014 to as low as $0.62 per share in late 2015.
On December 1, 2016, NASDAQ:BIOL shares closed at $1.65 per share.